Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.

Petsky HL, Cates CJ, Kew KM, Chang AB.

Thorax. 2018 Dec;73(12):1110-1119. doi: 10.1136/thoraxjnl-2018-211540. Epub 2018 Jun 1.

PMID:
29858277
2.

Shared decision-making for people with asthma.

Kew KM, Malik P, Aniruddhan K, Normansell R.

Cochrane Database Syst Rev. 2017 Oct 3;10:CD012330. doi: 10.1002/14651858.CD012330.pub2. Review.

3.

Lay-led and peer support interventions for adolescents with asthma.

Kew KM, Carr R, Crossingham I.

Cochrane Database Syst Rev. 2017 Apr 19;4:CD012331. doi: 10.1002/14651858.CD012331.pub2. Review.

4.

Interventions to improve adherence to inhaled steroids for asthma.

Normansell R, Kew KM, Stovold E.

Cochrane Database Syst Rev. 2017 Apr 18;4:CD012226. doi: 10.1002/14651858.CD012226.pub2. Review.

5.

Asthma education for school staff.

Kew KM, Carr R, Donovan T, Gordon M.

Cochrane Database Syst Rev. 2017 Apr 12;4:CD012255. doi: 10.1002/14651858.CD012255.pub2. Review.

6.

Interventions to improve inhaler technique for people with asthma.

Normansell R, Kew KM, Mathioudakis AG.

Cochrane Database Syst Rev. 2017 Mar 13;3:CD012286. doi: 10.1002/14651858.CD012286.pub2. Review.

7.

Exhaled nitric oxide levels to guide treatment for children with asthma.

Petsky HL, Kew KM, Chang AB.

Cochrane Database Syst Rev. 2016 Nov 9;11:CD011439. Review.

8.

Cognitive behavioural therapy (CBT) for adults and adolescents with asthma.

Kew KM, Nashed M, Dulay V, Yorke J.

Cochrane Database Syst Rev. 2016 Sep 21;9:CD011818. doi: 10.1002/14651858.CD011818.pub2. Review.

9.

Exhaled nitric oxide levels to guide treatment for adults with asthma.

Petsky HL, Kew KM, Turner C, Chang AB.

Cochrane Database Syst Rev. 2016 Sep 1;9:CD011440. doi: 10.1002/14651858.CD011440.pub2. Review.

10.

Intravenous magnesium sulfate for treating children with acute asthma in the emergency department.

Griffiths B, Kew KM, Normansell R.

Paediatr Respir Rev. 2016 Sep;20:45-47. doi: 10.1016/j.prrv.2016.07.001. Epub 2016 Jul 22. Review. No abstract available.

PMID:
27522304
11.

Home telemonitoring and remote feedback between clinic visits for asthma.

Kew KM, Cates CJ.

Cochrane Database Syst Rev. 2016 Aug 3;(8):CD011714. doi: 10.1002/14651858.CD011714.pub2. Review.

PMID:
27486836
12.

Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.

Kew KM, Quinn M, Quon BS, Ducharme FM.

Cochrane Database Syst Rev. 2016 Jun 7;(6):CD007524. doi: 10.1002/14651858.CD007524.pub4. Review.

PMID:
27272563
13.

Different oral corticosteroid regimens for acute asthma.

Normansell R, Kew KM, Mansour G.

Cochrane Database Syst Rev. 2016 May 13;(5):CD011801. doi: 10.1002/14651858.CD011801.pub2. Review.

PMID:
27176676
14.

Intravenous magnesium sulfate for treating children with acute asthma in the emergency department.

Griffiths B, Kew KM.

Cochrane Database Syst Rev. 2016 Apr 29;4:CD011050. doi: 10.1002/14651858.CD011050.pub2. Review.

PMID:
27126744
15.

Remote versus face-to-face check-ups for asthma.

Kew KM, Cates CJ.

Cochrane Database Syst Rev. 2016 Apr 18;4:CD011715. doi: 10.1002/14651858.CD011715.pub2. Review.

PMID:
27087257
16.

Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.

Kew KM, Dahri K.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011721. doi: 10.1002/14651858.CD011721.pub2. Review.

PMID:
26798035
17.

Macrolides for chronic asthma.

Kew KM, Undela K, Kotortsi I, Ferrara G.

Cochrane Database Syst Rev. 2015 Sep 15;(9):CD002997. doi: 10.1002/14651858.CD002997.pub4. Review.

PMID:
26371536
18.

Sublingual immunotherapy for asthma.

Normansell R, Kew KM, Bridgman AL.

Cochrane Database Syst Rev. 2015 Aug 28;(8):CD011293. doi: 10.1002/14651858.CD011293.pub2. Review.

PMID:
26315994
19.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.

Anderson DE, Kew KM, Boyter AC.

Cochrane Database Syst Rev. 2015 Aug 24;(8):CD011397. doi: 10.1002/14651858.CD011397.pub2. Review.

20.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.

Evans DJ, Kew KM, Anderson DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jul 21;(7):CD011437. doi: 10.1002/14651858.CD011437.pub2. Review.

21.

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.

Ahmad S, Kew KM, Normansell R.

Cochrane Database Syst Rev. 2015 Jun 19;(6):CD011306. doi: 10.1002/14651858.CD011306.pub2. Review.

PMID:
26089258
22.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.

Kew KM, Evans DJ, Allison DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jun 2;(6):CD011438. doi: 10.1002/14651858.CD011438.pub2. Review.

23.

Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids.

Kew KM, Beggs S, Ahmad S.

Cochrane Database Syst Rev. 2015 May 21;(5):CD011316. doi: 10.1002/14651858.CD011316.pub2. Review.

24.

Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department.

Kew KM, Kirtchuk L, Michell CI.

Cochrane Database Syst Rev. 2014 May 28;(5):CD010909. doi: 10.1002/14651858.CD010909.pub2. Review.

PMID:
24865567
25.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
26.

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Kew KM, Seniukovich A.

Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Review.

PMID:
24615270
27.

Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.

Cates CJ, Wieland LS, Oleszczuk M, Kew KM.

Cochrane Database Syst Rev. 2014 Feb 6;(2):CD010314. doi: 10.1002/14651858.CD010314.pub2. Review.

PMID:
24504983
28.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kew KM, Karner C, Mindus SM, Ferrara G.

Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019. doi: 10.1002/14651858.CD009019.pub2. Review.

PMID:
24343671
29.

Long-acting beta2-agonists for chronic obstructive pulmonary disease.

Kew KM, Mavergames C, Walters JA.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD010177. doi: 10.1002/14651858.CD010177.pub2. Review.

PMID:
24127118

Supplemental Content

Support Center